Literature DB >> 3989570

Rat brain mast cells: contribution to brain histamine levels.

R C Goldschmidt, L B Hough, S D Glick.   

Abstract

Recent studies have shown that mast cells (MCs) are present in rat brain, that they have a predominantly thalamic localization, and that they contain histamine (HA). However, the degree to which these cells contribute to brain HA levels has remained unclear. Our recent studies of the precise distribution of rat brain MCs permitted us to develop a method to determine both the MC numbers and HA content from the same brain. Thalamic MC numbers were highly correlated with both the amount (ng) and the concentration (ng/g) of thalamic HA in both sexes (p less than 0.005). Slopes of these regression lines, suggestive of the HA content of thalamic MCs, were 2.5 and 1.3 pg/cell in males and females, respectively, substantially less than the HA levels in peritoneal MCs. Thalamic MC numbers were not correlated with HA (ng) outside of thalamus, but were significantly (p less than 0.005) correlated with whole brain HA amounts (ng) and levels (ng/g). These results are direct biochemical evidence for a contribution by MCs to brain HA levels, and indicate that thalamic MCs contribute up to 90% of the HA in thalamus, and up to 50% of whole brain HA levels.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989570     DOI: 10.1111/j.1471-4159.1985.tb07191.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

1.  Mast cells in the sheep, hedgehog and rat forebrain.

Authors:  H C Michaloudi; G C Papadopoulos
Journal:  J Anat       Date:  1999-11       Impact factor: 2.610

Review 2.  Interactions of mast cells with the nervous system--recent advances.

Authors:  D Johnson; W Krenger
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

Review 3.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

4.  The intracerebroventricularly administered mast cells degranulator compound 48/80 increases the pituitary-adrenocortical activity in rats.

Authors:  A Gadek-Michalska; Z Chłap; M Turoń; J Bugajski; W A Fogel
Journal:  Agents Actions       Date:  1991-03

Review 5.  Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage.

Authors:  Perttu Johannes Lindsberg; Daniel Strbian; Marja-Liisa Karjalainen-Lindsberg
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

6.  Induction of IL-33 expression and activity in central nervous system glia.

Authors:  Chad A Hudson; George P Christophi; Ross C Gruber; Joel R Wilmore; David A Lawrence; Paul T Massa
Journal:  J Leukoc Biol       Date:  2008-06-13       Impact factor: 4.962

Review 7.  Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives.

Authors:  W M Purcell; C K Atterwill
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

8.  Effect of histamine on the development of astroglial cells in culture.

Authors:  J Rodriguez; J Moran; I Blanco; A J Patel
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

9.  Spontaneous locomotor activity correlates with the degranulation of mast cells in the meninges rather than in the thalamus: disruptive effect of cocaine.

Authors:  Alice A Larson; Mark J Thomas; Alex McElhose; Katalin J Kovács
Journal:  Brain Res       Date:  2011-04-28       Impact factor: 3.252

10.  Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Authors:  Seiji Nishino; Eiko Sakurai; Sona Nevsimalova; Yasushi Yoshida; Takehiko Watanabe; Kazuhiko Yanai; Emmanuel Mignot
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.